The curious case of miR-155 in SLE

Area of Science:

• Immunology and Genetics
• Molecular Biology
• Autoimmune Diseases Research

Background:

• Epigenetic modifications are implicated in autoimmune diseases.
• MicroRNAs (miRNAs) are critical regulators in immune system development and function.
• Systemic lupus erythematosus (SLE) remains an incurable autoimmune disease despite treatment advancements.

Purpose of the Study:

• To review the role of microRNA-155 (miR-155) in systemic lupus erythematosus (SLE).
• To explore miR-155 as a potential biomarker and therapeutic target in SLE.
• To discuss the functions of miR-155 in SLE patients and animal models, addressing study inconsistencies.

Main Methods:

• Literature review of studies on miR-155 in SLE.
• Analysis of miR-155's involvement in immune system development and autoimmunity.
• Examination of miR-155's role in SLE pathogenesis and potential as a therapeutic target.

Main Results:

• MicroRNA-155 (miR-155) is significantly involved in the pathogenesis of systemic lupus erythematosus (SLE).
• miR-155 functions as a potential biomarker for SLE diagnosis and prognosis.
• Inconsistencies in study findings regarding miR-155's role in SLE warrant further investigation.

Conclusions:

• miRNA-targeted therapy, particularly involving miR-155, shows promise for treating autoimmune diseases like SLE.
• The dual role of miRNAs, including miR-155, necessitates careful consideration in therapeutic strategies.
• Further research is needed to elucidate the complex functions of miR-155 in SLE for effective treatment development.